View Archive

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Daiichi Sankyo.

ESMO Asia Virtual Congress 2020 Industry Satellite Symposium

Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumor Perspective

Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumor Perspective

Saturday, 21 November 2020

12:00 - 13:30 SGT


The targeting of tumor cell surface antigens remains a key therapeutic approach in oncology. Antibody-drug conjugates (ADCs) combine the specificity of a tumor-targeting antibody with a cytotoxic payload. Several ADCs have been approved, with additional agents in development, which target an expanding range of tumor antigens, including HER2, HER3, and Trop-2, as well as several other molecules. The expanding therapeutic options provided by ADCs create an educational need for physicians to learn about how to optimize the use of these agents in clinical practice, as well as best approaches for biomarker assessment and management of adverse events.

Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumor Perspective will feature Asian and other global experts in breast, lung, and gastrointestinal (GI) malignancies, and will begin with a rapid overview of key concepts in ADCs, including therapeutic targets and biomarker testing. The expert faculty will address approvals and clinical data illustrating areas of potential application for ADCs in specific tumor types. Potential combinations and future treatment approaches with ADCs will also be discussed. Be sure to join us for this exciting symposium illustrating how ADCs can improve care for your patients.

Benefits of Attending

  • Learn about potential new applications for ADCs in solid tumors
  • Hear expert perspectives on managing adverse events associated with ADC therapy
  • Integrate cutting-edge therapies for your patients with breast, lung, or GI tumors

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Daiichi Sankyo.

Target Audience

This educational program is directed toward a global audience of medical oncologists, pathologists, and fellows interested in the treatment of cancer. Nurse practitioners, physician assistants, nurses, pulmonologists, and other health care professionals involved in the treatment and management of patients with cancer will also be invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Determine the rationale underlying the use of antibody-drug conjugates in solid tumors
  • Apply optimized HER2-testing strategies to facilitate molecular characterization of solid tumors
  • Evaluate ongoing clinical trials and evolving data sets for novel antibody-drug conjugate targeted therapies across solid tumors
  • Integrate novel antibody-drug conjugate approaches into care for patients with a variety of solid tumor types

Program Chair

Masakazu Toi, MD, PhD
Masakazu Toi, MD, PhD
Breast Cancer Unit, Kyoto University Hospital
Professor of Breast Surgery,
Graduate School of Medicine, Kyoto University
Kyoto, Japan


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By